#GLP-1 (3)
-
GLP-1 and Appetite: How Weight-Loss Drugs Rewire the Brain
GLP-1 drugs suppress appetite through brain pathways that control reward and satiety—effects extending beyond blood sugar to food cravings, gastric emptying, and even addictive behaviors.
-
New Insulin Guidelines Tackle Access and Adjunct Treatments
Did you know? The 2024 international guidelines for young people with diabetes now include recommendations on newer insulin formulations and adjunct medications like GLP-1 drugs, while emphasizing that access and affordability remain critical barriers worldwide.
-
GLP-1 and Appetite: How Weight-Loss Drugs Rewire Cravings for Food, Alcohol, and Drugs
Surprising finding: Medications designed for weight loss, including semaglutide and liraglutide, are being linked to reduced cravings for alcohol and drugs, suggesting they may affect reward-seeking behavior more broadly than just food intake.